We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Biomerica INC (BMRA) USD0.08

Sell:$0.30 Buy:$0.34 Change: $0.0133 (3.87%)
Market closed |  Prices as at close on 26 September 2024 | Switch to live prices |
Sell:$0.30
Buy:$0.34
Change: $0.0133 (3.87%)
Market closed |  Prices as at close on 26 September 2024 | Switch to live prices |
Sell:$0.30
Buy:$0.34
Change: $0.0133 (3.87%)
Market closed |  Prices as at close on 26 September 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.

Contact details

Address:
17571 VON KARMAN AVENUE
IRVINE
92614
United States
Telephone:
+1 (949) 3792875
Website:
https://biomerica.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
BMRA
ISIN:
US09061H3075
Market cap:
$5.77 million
Shares in issue:
16.82 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Zackary Irani
    Chief Executive Officer
  • Allen Barbieri
    Lead Executive Vice Chairman of the Board, Corporate Secretary
  • Gary Lu
    Chief Financial Officer
  • Robert Carlson
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.